Intrinsic value of Kymera Therapeutics, Inc. (KYMR)

Live fair value data for Kymera Therapeutics, Inc. (KYMR) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +26.0%

Margin of Safety: +20.6%

Current Price: $183.00

Valuation: Undervalued

Confidence: 6.5/10

Visual Bar

Market Price $183.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is Kymera Therapeutics, Inc. (KYMR) undervalued or overvalued?

Based on the current model output, Kymera Therapeutics, Inc. appears to be undervalued with a upside of 26.00%.

Fair value vs market price — Kymera Therapeutics, Inc. (KYMR)

Unlock premium access to view the live fair value comparison against current market price for KYMR.

Frequently Asked Questions - KYMR

How is KYMR intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for KYMR.

Is KYMR undervalued or overvalued right now?

KYMR is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for KYMR: open their intrinsic value pages.

Explore Other Stocks